Will NCT04529772 (Acerta Pharma BV) still show a study completion date of 22 February 2027 or earlier when checked on 24 March 2027?
deadline 2027-03-24
confidence medium
tier 4 evidence
59%PolySignal estimate
Resolution criterion
Yes if, when NCT04529772 is read on clinicaltrials.gov on 24 March 2027, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 22 February 2027 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used.
Verified starting state
As of 27 September 2026: NCT04529772 is registered as ACTIVE_NOT_RECRUITING, sponsored by Acerta Pharma BV, with 611 participants. Started 2020-10; announced primary completion 2027-02-22, announced study completion 2027-02-22. Record last updated 2026-06-25. The date under test is 2027-02-22. Source: clinicaltrials.gov/study/NCT04529772
What pushes it up
- The trial has completed recruitment and has an exact-day completion date of 2027-02-22 that was reaffirmed in the recent update on 2026-06-25 [1].
- With less than five months remaining until February 2027, the window for unexpected operational delays is relatively narrow [1].
What pushes it down
- Clinical trials frequently push back completion dates due to extended patient follow-up, event-driven endpoint timing, or administrative data-lock delays [1].
- Any pushback beyond 2027-02-22 or a lapse into Unknown/Suspended/Terminated status results in a No resolution [1].
What would move this number most
Whether patient follow-up or primary endpoint evaluation requires extending the study beyond February 2027.
How this number is built
| Deadline | 2027-03-24 |
| Base rate | 60% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 55 · 62 (spread 7 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-09-27 02:35 |
| Model | gemini-3.7-flash |